Abstract
Background Transthyretin Familial Amyloid Polyneuropathy (TTRFAP) is a rare, progressive, debilitating and life-threatening neurodegenerative disease. TTR-FAP is a rare disease worldwide. In Europe a disease is defined as rare when it affects less than 1 in 2000 inhabitants. Portugal has the largest cluster worldwide nonetheless recent Portuguese epidemiologic data is lacking. The purpose of this study is to estimate TTR-FAP prevalence in Portugal.
Highlights
Transthyretin Familial Amyloid Polyneuropathy (TTRFAP) is a rare, progressive, debilitating and life-threatening neurodegenerative disease
Portuguese total population by municipality was obtained from the official source - Instituto Nacional de Estatística
Trough year 2014, a total of 70286 electronic dispensing acts were detected in Administração Central do Sistema Saúde (ACSS) database, unravelling a total of 2013 distinctive TTR-FAP patients in Portugal
Summary
The purpose of this study is to estimate TTR-FAP prevalence in Portugal
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
